Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilio Jirillo

Showing results (41-50 of 146) with videos related to

Pageof 15
Sort By:
Endocrine, Metabolic & Immune Disorders Drug Targets|March 10, 2020
Eosinophils, a Jack of All Trades in Immunity: Therapeutic Approaches for Correcting Their Functional DisordersThea Magrone, Manrico Magrone, Emilio Jirillo
Endocrine, Metabolic & Immune Disorders Drug Targets|December 3, 2019
Mast Cells as a Double Edged Sword in Immunity: Disorders of Mast Cell Activation and Therapeutic Management. Second of Two PartsThea Magrone, Manrico Magrone, Emilio Jirillo
Endocrine, Metabolic & Immune Disorders Drug Targets|March 11, 2014
Correlations between the Youth Healthy Eating Index, body mass index and the salivary nitric oxide concentration in overweight/obese childrenElsa Vitale, Emilio Jirillo, Thea Magrone
Current Pharmaceutical Design|March 20, 2010
Low grade inflammation as a common pathogenetic denominator in age-related diseases: novel drug targets for anti-ageing strategies and successful ageing achievement. Part IICalogero Caruso, Thea Magrone, Emilio Jirillo
Endocrine, Metabolic & Immune Disorders Drug Targets|April 28, 2020
Focus on Receptors for Coronaviruses with Special Reference to Angiotensin- Converting Enzyme 2 as a Potential Drug Target - A PerspectiveThea Magrone, Manrico Magrone, Emilio Jirillo
Current Pharmaceutical Design|March 20, 2010
Low grade inflammation as a common pathogenetic denominator in age-related diseases: novel drug targets for anti-ageing strategies and successful ageing achievement. Part ICalogero Caruso, Thea Magrone, Emilio Jirillo
Endocrine, Metabolic & Immune Disorders Drug Targets|December 3, 2019
Mast Cells as a Double-Edged Sword in Immunity: Their Function in Health and Disease. First of Two PartsThea Magrone, Manrico Magrone, Emilio Jirillo
Recent Patents on CNS Drug Discovery|January 29, 2008
Voltage-gated sodium channel blockers as immunomodulatorsFrancesco Roselli, Paolo Livrea, Emilio Jirillo
International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift Fur Vitamin- Und Ernahrungsforschung. Journal International De Vitaminologie Et De Nutrition|December 22, 2012
Healthy effects exerted by prebiotics, probiotics, and symbiotics with special reference to their impact on the immune systemEmilio Jirillo, Felicita Jirillo, Thea Magrone
Toxics|April 25, 2025
Pathophysiology of Doxorubicin-Mediated CardiotoxicityRoberto Arrigoni, Emilio Jirillo, Carlo Caiati
Pageof 15

Showing results (41-50 of 146) with videos related to

Sort By:
Pageof 15
Endocrine, Metabolic & Immune Disorders Drug Targets|March 10, 2020
Eosinophils, a Jack of All Trades in Immunity: Therapeutic Approaches for Correcting Their Functional DisordersThea Magrone, Manrico Magrone, Emilio Jirillo
Endocrine, Metabolic & Immune Disorders Drug Targets|December 3, 2019
Mast Cells as a Double Edged Sword in Immunity: Disorders of Mast Cell Activation and Therapeutic Management. Second of Two PartsThea Magrone, Manrico Magrone, Emilio Jirillo
Endocrine, Metabolic & Immune Disorders Drug Targets|March 11, 2014
Correlations between the Youth Healthy Eating Index, body mass index and the salivary nitric oxide concentration in overweight/obese childrenElsa Vitale, Emilio Jirillo, Thea Magrone
Current Pharmaceutical Design|March 20, 2010
Low grade inflammation as a common pathogenetic denominator in age-related diseases: novel drug targets for anti-ageing strategies and successful ageing achievement. Part IICalogero Caruso, Thea Magrone, Emilio Jirillo
Endocrine, Metabolic & Immune Disorders Drug Targets|April 28, 2020
Focus on Receptors for Coronaviruses with Special Reference to Angiotensin- Converting Enzyme 2 as a Potential Drug Target - A PerspectiveThea Magrone, Manrico Magrone, Emilio Jirillo
Current Pharmaceutical Design|March 20, 2010
Low grade inflammation as a common pathogenetic denominator in age-related diseases: novel drug targets for anti-ageing strategies and successful ageing achievement. Part ICalogero Caruso, Thea Magrone, Emilio Jirillo
Endocrine, Metabolic & Immune Disorders Drug Targets|December 3, 2019
Mast Cells as a Double-Edged Sword in Immunity: Their Function in Health and Disease. First of Two PartsThea Magrone, Manrico Magrone, Emilio Jirillo
Recent Patents on CNS Drug Discovery|January 29, 2008
Voltage-gated sodium channel blockers as immunomodulatorsFrancesco Roselli, Paolo Livrea, Emilio Jirillo
International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift Fur Vitamin- Und Ernahrungsforschung. Journal International De Vitaminologie Et De Nutrition|December 22, 2012
Healthy effects exerted by prebiotics, probiotics, and symbiotics with special reference to their impact on the immune systemEmilio Jirillo, Felicita Jirillo, Thea Magrone
Toxics|April 25, 2025
Pathophysiology of Doxorubicin-Mediated CardiotoxicityRoberto Arrigoni, Emilio Jirillo, Carlo Caiati
Pageof 15